Bus. & Prof. Code, § 4920

For the purposes of this article, the following definitions apply:

(a) “Adverse event” means an event in which an animal is injured, sickened, rendered unconscious, or killed.

(b) “Blood and blood component products” has the same meaning as in Section 9201 of the Food and Agricultural Code and means whole blood collected directly from a donor animal for transfusion or the blood components for transfusion, including packed red blood cells, platelet-rich plasma, platelet concentrates, fresh plasma, fresh frozen plasma, frozen plasma, cryoprecipitate, and cryosupernatant. Antibody products like hyperimmune serums are considered “biologics” and are excluded from this definition of blood and blood component products.

(c) “Captive closed colony” means that an animal is kept, housed, or maintained in any way for the purpose of collecting its blood.

(d) “Closed-colony blood bank” means a commercial blood bank for animals that produces animal blood or blood component products solely from animals held in a captive closed colony.

(e) “Commercial blood bank for animals” means an establishment that produces animal blood or blood component products from captive closed-colony or community-sourced animals to market and sell for use in the cure, mitigation, treatment, or prevention of injury or disease in animals.

(f) “Community blood bank” means a commercial blood bank for animals that produces animal blood or blood component products solely from community-sourced animals whose owners voluntarily consent to the donation.

(g) “Community sourced” means that an animal is all of the following:

(1) Kept, housed, and maintained at the residence of its owner who is a person and not a partnership, association, corporation, or limited liability company.

(2) Brought by its owner to a community blood bank for animals to have its blood collected.

(3) Licensed in accordance with any pet licensing required by the pet owner’s state, county, or city of residence.

(h) “Production” means the collection of blood or the preparation, testing, processing, storage, or distribution of blood or blood component products for purpose of transfusion.